First Advantage (NASDAQ:FA) reported quarterly earnings of $0.25 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $201.56 million which beat the analyst consensus estimate of $199.34 million by 1.11 percent. This is a 15.29 percent increase over sales of $174.83 million the same period last year.
Syndax Pharmaceuticals Set for Potential Breakthrough with Revumenib: Analyst Calls It ‘Potentially Best-In-Class’ In Competitive Landscape
Guggenheim Partners initiated coverage on Syndax Pharmaceuticals Inc (NASDAQ: SNDX) with a BUY rating and a
